Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.

Triple negative (ER, PgR and HER2 negative) breast cancers (TNBCs) are often considered as a poor prognostic phenotype. There is dearth of evidence showing the prevalence and biological behaviour of TNBCs in older women. This study aimed to analyse their biological characteristics in comparison with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Binafsha M Syed, Andrew R Green, Christopher C Nolan, David A L Morgan, Ian O Ellis, Kwok-Leung Cheung
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3cb728eb884a4262bc0b8131b5c19aef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3cb728eb884a4262bc0b8131b5c19aef
record_format dspace
spelling oai:doaj.org-article:3cb728eb884a4262bc0b8131b5c19aef2021-11-25T06:09:35ZBiological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.1932-620310.1371/journal.pone.0100573https://doaj.org/article/3cb728eb884a4262bc0b8131b5c19aef2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24999743/?tool=EBIhttps://doaj.org/toc/1932-6203Triple negative (ER, PgR and HER2 negative) breast cancers (TNBCs) are often considered as a poor prognostic phenotype. There is dearth of evidence showing the prevalence and biological behaviour of TNBCs in older women. This study aimed to analyse their biological characteristics in comparison with a well characterised younger series from a single centre with long term clinical follow-up. Over 37 years (1973-2010), 1,758 older (≥70 years) women with early operable (<5 cm) primary breast cancer were managed in a dedicated clinic and have complete clinical information available. Of these 813 patients underwent primary surgery and 575 had good quality tumour samples available for tissue microarray analysis using indirect immunohistochemistry. A total of 127 patients (22.1%) had TNBCs and full biological analysis of 15 biomarkers was performed. The results were compared with those of their younger (<70 years) counterparts 342 (18.9%) from a previously characterised, consecutive series of primary breast cancer treated in the same unit (1986-1998). The 127 older patients with TNBCs showed lower rates of Ki67 and CK 7/8 positivity and high rates of bcl2 and CK18 positivity when compared with their younger counterparts (p<0.05). There was no significant difference in the long term clinical outcome between the two age groups, despite the fact that 47% of the younger patients had adjuvant chemotherapy, while none in the older cohort received such treatment. EGFR, axillary stage and pathological size showed prognostic significance in older women with TNBCs on univariate analysis. Despite not having received adjuvant chemotherapy, the older series had clinical outcome similar to the younger patients almost half of whom had chemotherapy. This appears to be related to other biomarkers (in addition to ER/PgR/HER2) eg Ki67, bcl2 and cytokeratins which have different expression patterns influencing prognosis.Binafsha M SyedAndrew R GreenChristopher C NolanDavid A L MorganIan O EllisKwok-Leung CheungPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 7, p e100573 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Binafsha M Syed
Andrew R Green
Christopher C Nolan
David A L Morgan
Ian O Ellis
Kwok-Leung Cheung
Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.
description Triple negative (ER, PgR and HER2 negative) breast cancers (TNBCs) are often considered as a poor prognostic phenotype. There is dearth of evidence showing the prevalence and biological behaviour of TNBCs in older women. This study aimed to analyse their biological characteristics in comparison with a well characterised younger series from a single centre with long term clinical follow-up. Over 37 years (1973-2010), 1,758 older (≥70 years) women with early operable (<5 cm) primary breast cancer were managed in a dedicated clinic and have complete clinical information available. Of these 813 patients underwent primary surgery and 575 had good quality tumour samples available for tissue microarray analysis using indirect immunohistochemistry. A total of 127 patients (22.1%) had TNBCs and full biological analysis of 15 biomarkers was performed. The results were compared with those of their younger (<70 years) counterparts 342 (18.9%) from a previously characterised, consecutive series of primary breast cancer treated in the same unit (1986-1998). The 127 older patients with TNBCs showed lower rates of Ki67 and CK 7/8 positivity and high rates of bcl2 and CK18 positivity when compared with their younger counterparts (p<0.05). There was no significant difference in the long term clinical outcome between the two age groups, despite the fact that 47% of the younger patients had adjuvant chemotherapy, while none in the older cohort received such treatment. EGFR, axillary stage and pathological size showed prognostic significance in older women with TNBCs on univariate analysis. Despite not having received adjuvant chemotherapy, the older series had clinical outcome similar to the younger patients almost half of whom had chemotherapy. This appears to be related to other biomarkers (in addition to ER/PgR/HER2) eg Ki67, bcl2 and cytokeratins which have different expression patterns influencing prognosis.
format article
author Binafsha M Syed
Andrew R Green
Christopher C Nolan
David A L Morgan
Ian O Ellis
Kwok-Leung Cheung
author_facet Binafsha M Syed
Andrew R Green
Christopher C Nolan
David A L Morgan
Ian O Ellis
Kwok-Leung Cheung
author_sort Binafsha M Syed
title Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.
title_short Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.
title_full Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.
title_fullStr Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.
title_full_unstemmed Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.
title_sort biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/3cb728eb884a4262bc0b8131b5c19aef
work_keys_str_mv AT binafshamsyed biologicalcharacteristicsandclinicaloutcomeoftriplenegativeprimarybreastcancerinolderwomencomparisonwiththeiryoungercounterparts
AT andrewrgreen biologicalcharacteristicsandclinicaloutcomeoftriplenegativeprimarybreastcancerinolderwomencomparisonwiththeiryoungercounterparts
AT christophercnolan biologicalcharacteristicsandclinicaloutcomeoftriplenegativeprimarybreastcancerinolderwomencomparisonwiththeiryoungercounterparts
AT davidalmorgan biologicalcharacteristicsandclinicaloutcomeoftriplenegativeprimarybreastcancerinolderwomencomparisonwiththeiryoungercounterparts
AT ianoellis biologicalcharacteristicsandclinicaloutcomeoftriplenegativeprimarybreastcancerinolderwomencomparisonwiththeiryoungercounterparts
AT kwokleungcheung biologicalcharacteristicsandclinicaloutcomeoftriplenegativeprimarybreastcancerinolderwomencomparisonwiththeiryoungercounterparts
_version_ 1718414095637544960